Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 463.56% and ...

J&J, GSK, Eli Lilly and others struck high-value transactions in the early days of biopharma’s annual kickoff conference.

Omvoh’s label expansion is important progress for Eli Lilly as it works to diversify its portfolio beyond obesity, according ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eli Lilly has agreed ... Equity Partners. For Lilly, the agreement comes a couple of months after it completed a takeover of German ADC specialist Emergence Therapeutics and its lead candidate ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

After several years in the doldrums, pharmaceutical companies and biotechs expect an uptick in dealmaking in 2025, with some ...

Eli Lilly’s acquisition of gene therapy specialist ... called DB-OTO from its $109 million acquisition of Decibel Therapeutics last year – and French biotech Sensorion. Regeneron reported ...

Donald Trump's nominees for top national security jobs said they would not prioritize their loyalty to the president-elect over their duty to the country in U.S. Senate hearings on Wednesday ...

AFP becomes one of the main source for international news. We've got various news from around the world. I can say that AFP news content is diverse and credible, and they can fit with the ...